Sheree R. Kanner is named as a lobbyist on federal disclosure filings for 9 clients through Hogan Lovells Cadwalader US LLP (fka Hogan Lovells US Llp). The most recent filing naming them posted in July 2018. Issues reported include Medicare/Medicaid and Health Issues.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PRITIKIN LONGEVITY CENTER & SPA | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q2 2018 | Medicare/Medicaid |
| SUMMA HEALTH | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q4 2016 | Medicare/Medicaid |
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q2 2013 | Medicare/Medicaid, Health Issues |
| AMERICAN HOSPITAL ASSOCIATION | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q2 2013 | Medicare/Medicaid, Health Issues |
| FAIR ISAAC CORPORATION DBA FICO | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q1 2013 | Medicare/Medicaid |
| SANOFI US SERVICES INC F/K/A SANOFI-AVENTIS U S INC | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q3 2008 | Medicare/Medicaid, Health Issues |
| TAP PHARMACEUTICALS INC | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q2 2008 | Medicare/Medicaid |
| OHIO STATE UNIVERSITY | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q2 2008 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| UNITEDHEALTH GROUP | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | Q1 2008 | Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2018 | 1 | 1 |
| 2017 | 1 | 1 |
| 2016 | 2 | 1 |
| 2015 | 1 | 1 |
| 2014 | 1 | 1 |
| 2013 | 3 | 1 |
| 2012 | 2 | 1 |
| 2011 | 1 | 1 |
| 2009 | 1 | 1 |
| 2008 | 4 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Sheree R. Kanner. See the Capitol Clarity rankings and method.